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ABSTRACT 
Objective: To develop a cheap and rapid UV spectrophotometric method for the quantitative estimation of Indinavir sulphate (400mg) in capsules 
and validate as per ICH guidelines.  
Methods: The optimized method uses a diluent 100% potassium dihydrogen ortho phosphate buffer (pH 3.0) for the estimation of assay of 
Indinavir sulphate whose λmax is 259 nm.  
Results: The developed method resulted in Indinavir sulphate exhibiting linearity in the range 20-80 μg/ml. The precision is exemplified by relative 
standard deviation of 1.49%. Percentage Mean recovery was found to be in the range of 98-102, during accuracy studies. The limit of detection 
(LOD) and limit of quantitiation (LOQ) were found to be 5 µg/ml, and 16.27 µg/ml respectively.  
Conclusion: A cheap and rapid UV spectrophotometric method was developed and validated for the quantitative estimation of Indinavir sulphate in 
capsules as per ICH guidelines and hence it can be used for the routine analysis in various pharmaceutical industries.  
Keywords: UV, Indinavir sulphate, Method development, Validation. 
 
 
Fig. 1: Structure of Indinavir sulphate 
 
INTRODUCTION 
Indinavir sulphate (Figure 1) is a human immunodeficiency virus 
(HIV) protease inhibitor used for treating acquired immune 
deficiency syndrome (AIDS). Indinavir sulphate is usually prescribed 
in combination with other protease inhibitors, nucleoside analogues 




namide sulphate (1:1) salt.  
The drug has a molar mass of 613.88 g/mol for the free base and 
711.88 g/mol for the sulphate salt and is commercially available as 
capsules (trade name: INDIVAN) containing the equivalent of 400 
mg of indinavir free base. 
A detailed literature survey reveals LC methods for the analysis of 
Indinavir sulphate individually and in various combinations in 
biological matrices[4-10], capillary zone electrophoresis method for 
the analysis of indinavir sulphate raw material[11], few RP-HPLC 
methods for the determination of assay of Indinavir in bulk and in 
capsule dosage forms[12-13]. There exists only one UV 
spectrophotometric method reported for the determination of assay 
of Indinavir sulphate in capsule dosage forms using bromocresol 
purple and bromothymol blue[14]. Hence we here report a new, 
cheap and rapid UV spectrophotometric method for the quantitative 
estimation of Indinavir sulphate in INDIVAN capsules.  
MATERIALS AND METHODS 
Materials 
Instrument 
A double beam UV-visible spectrophotometer (Shimadzu, model 
1800) having two matched quartz cells with 1 cm light path and 
loaded with UV probe software (version 2.41) was used for 
recording of spectra and measuring absorbance. An electronic 
analytical weighing balance (0.1mg sensitivity, Shimadzu AY 220), 
digital pH meter (DELUX model 101) and a sonicator (sonica, model 
2200 MH) were used in this study.  
Chemicals and Reagents 
Analytically pure sample of Indinavir sulphate with purities greater 
than 99% was obtained as gift sample from Chandra labs, 
Hyderabad, India and tablet formulation [INDIVAN] was procured 
from MEDPLUS, Hyderabad, India with labelled amount 400mg of 
Indinavir sulphate.  Potassium dihydrogen ortho phosphate (AR 
Grade) and ortho phosphoric acid (AR Grade) were obtained from 
SD Fine chemicals (Hyderabad, India). 0.45μm Nylon membrane 
filters were obtained from Spincotech Private Limited, Hyderabad, 
India. 
Method 
Solvent: Solvent used is prepared by adding 2.72 grams of 
potassium dihydrogenortho phosphate to 1000 ml of distilled water 
and later pH was adjusted to 3.0 using 30% v/v of ortho phosphoric 
acid in water. Solvent was then filtered through 0.45 μm nylon 
membrane filter.  
Selection of suitable detection wavelength 
Suitable wavelength for the total experiment was determined by 
recording UV spectrum in the range of 200-400 nm for Indinavir 
sulphate and suitable wavelength selected was 259 nm (Figure 2). 
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Fig. 2: UV spectrum of Indinavir sulphate 
 
Preparation of stock and working standard solution 
10mg of Indinavir sulphate was accurately weighed and taken in 
100ml clean and dry volumetric flask containing 80ml of solvent and 
then the solution was made up to the mark using the solvent. This is 
considered as standard stock solution (100µg/ml). 4ml of the stock 
solution was pipetted out and made up to 10 ml to get a 
concentration 40µg/ml, treated as working standard, 100% target 
concentration.  
Preparation of stock and working sample solution 
Ten tablets were weighed separately and the average weight was 
determined. The average weight was weighed from the ten tablets 
grinded in a pestle and mortar, transferred to a 100 ml volumetric 
flask containing 100ml diluent and then stirred for 10 minutes, 
followed by filtration through 0.45µ nylon membrane filter to get 
sample stock solution of 4mg/ml. 1 ml of the above stock solution 
was pipetted out and made up to 100 ml to get working sample 
solution equivalent to a concentration of working standard of 40 
µg/ml. 
RESULTS AND DISCUSSION 
Method Development 
Various solvents were explored, including Potassium dihydrogen 
orthophosphate, triethylammonium phosphate and ammonium 
acetate buffers varying pH in the ranges of 2-7. Indinavir sulphate 
was found to be soluble and stable for minimum of 1 hour at room 
temperature using pH 3.0 Potassium dihydrogen orthophosphate 
buffer and hence this buffer was initiated for the determination of 
suitable detection wavelength and working concentration of 
standard. In order to test the applicability of the developed method 
to a commercial formulation, INDIVAN was studied at working 
concentration.  
Absorbance and assay for working concentration of sample at 259 
nm was in acceptance limits (98-102%) with the standard working 
concentration during extraction of drug in the sample using the 
solvent for 10 minutes. The protocol affords reproducible 
quantification of the drug in the sample ranging between 98 and 
102%, which is the standard level in any pharmaceutical quality 
control. Hence the method is optimized.  
Method validation 
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical 
application. UV spectrophotometric method developed was 
validated according to International Conference on Harmonization 
(ICH) guidelines [15] for validation of analytical procedures. The 
method was validated for the parameters like linearity, accuracy, 
system precision, intra-day precision, inter-day precision/ 
intermediate precision/ ruggedness, robustness, limit of detection 
(LOD) and limit of quantitiation (LOQ). 
Precision 
System precision 
Six replicate recording of absorbance at 259nm of standard solution 
at working concentration showed % RSD (Relative Standard 
Deviation) less than 2 concerning absorbance for the drug, which 
indicates the acceptable reproducibility and thereby the precision of 
the system. System precision results are tabulated in Table 1. 
Method precision 
Method precision was determined by performing assay of sample 
under the tests of (i) repeatability (Intra day precision) and (ii) 
Intermediate precision (Inter day precision) performed during 3 
consecutive days by three different analysts, at working 
concentration.  
 
Table 1: System precision results of Indinavir sulphate. 







 Average 0.336 
 SD 0.005 
 % RSD 1.48 
 
Repeatability (Intra day precision) 
Six consecutive recording of absorbance at 259nm of the sample 
from the same homogeneous mixture at working concentration 
showed % RSD less than 2 concerning % assay for the drug which 
indicate that the method developed is method precise by the test of 
repeatability and hence can be understood that the method gives 
consistently reproducible results (Table 2).  
 
Table 2: Intra day precision results of Indinavir sulphate 









% RSD 1.49 
 
Intermediate Precision (Inter day precision / Ruggedness) 
Six consecutive recording of absorbance at 259nm of the sample 
solution from the same homogeneous mixture at working 
concentration on three consecutive days by three different analysts, 
showed % RSD less than 2 for % assay for the drug within and 
between days, which indicate the method developed is inter day 
precise / rugged (Table 3). 
Linearity 
Standard solutions of Indinavir sulphate at different concentrations 
level (50%, 75%, 100%, 125%, 150%, 175% and 200%) were 
prepared. Calibration curve was constructed by plotting the 
concentration level of drug versus corresponding absorbance at 
259nm. The results show an excellent correlation between 
absorbance and concentration level of drug within the concentration 
range (20-80 µg/ml) for the drug and the results are given in Table 
4. The correlation coefficients were greater than 0.995, which meet 
the method validation acceptance criteria and hence the method is 
said to be linear in the range of 20-80 µg/ml. 
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Table 3: Inter day precision results. 
n Day 1 Day 2 Day 3 
1 98.6  100.68  99.45 
2 98.1  101.1  99.32 
3 101.2  101.3 98.3 
4 99.5  100.6 100.1 
5 101.8  100.2 100.2 
6 100.3  99.8  99.43 
Average 99.91 100.61 99.46 
SD 1.49 0.555 0.681 
% RSD 1.49 0.55 0.68 
 
Table 4: Calibration data for indinavir sulphate 








50 20 0.182 0.160 0.168 
75 30 0.244 0.228 0.221 
100 40 0.335 0.320 0.313 
125 50 0.426 0.408 0.396 
150 60 0.513 0.484 0.499 
175 70 0.596 0.582 0.591 
200 80 0.689 0.673 0.680 
Regression equation  y = 0.0085x-0.0026 y = 0.0086x-0.0226 y = 0.0087x-0.0299 
Regression coefficient  0.9983 0.9984 0.995 
 
Table 5: Results of accuracy studies for indinavir sulphate 




*Mean of three replicates 
 
Table 6: Robustness results of indinavir sulphate sample 
Variation parameter Variation %RSD  
pH(± 0.2) 3.2 0.796 
 3 1.702 
 2.8 0.813 
Wave length  
(± 2nm) 
261 1.003 
 259 0.45 
 257 1.298 
 
Table 7: Optical characteristics and validation parameters of Indinavir sulphate 
Parameters Results 
Detection wavelength (nm) 259 
Beer’s Law limits (µg/ml) 20 - 80 
Sandell’s sensitivity (µg/cm2 0.009 /0.001 absorbance unit) 
Regression equation (y = mx+c) y = 0.0086-0.0183 
Correlation coefficient (r2 0.9972 ) 
Slope (m) 0.0086 
Intercept (c) -0.0183 
% Relative Standard Deviation (% RSD) System precision 1.48 
(% RSD) Intra-day precision 1.49 
(% RSD) Inter-day precision ≤ 2 
Accuracy (% Mean Recovery)  
 50 % Level 99.5 
 100 % Level 100.3 
 150 % Level 99.26 
LOD (µg/ml) 5 
LOQ (µg/ml) 16.27 
Robustness  
pH(± 0.2) (% RSD) ≤ 2 
Wavelength (± 2nm) (% RSD) ≤ 2 
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Accuracy 
Accuracy was determined by means of recovery experiments, by the 
determination of % mean recovery of sample at three different 
levels (50-150%). At each level, three determinations were 
performed. Percent mean recovery was calculated as shown in 
Table 5. The accepted limits of recovery are 98% - 102% and all 
observed data are within the required range which indicates good 
recovery values and hence the accuracy of the method developed. 
Robustness 
The robustness of an analytical method is a measure of its capacity 
to remain unaffected by small but deliberate variations in method 
parameters and provides an indication of its reliability during 
normal usage. It is concluded that the method is robust as it is found 
that the % RSD is less than 2 for the drug concerning % assay 
despite deliberate variations done concerning pH ± 0.2 and 
detection wavelength ± 2nm (Table 6). 
Sensitivity 
The sensitivity of measurement of Indinavir sulphate by use of the 
proposed method was estimated in terms of the limit of quantitation 
(LOQ), limit of detection (LOD) and Sandell’s sensitivity. The limit of 
detection (LOD) and limit of quantitiation (LOQ) were found to be 5 
µg/ml, and 16.27 µg/ml respectively. Optical characteristics and 
validation parameters results are summarized in Table 7. 
CONCLUSION 
A cheap and rapid UV spectrophotometric method was developed 
and validated for the quantitative estimation of Indinavir sulphate in 
capsules as per ICH guidelines. The developed method resulted in 
Indinavir sulphate exhibiting linearity in the range 20-80 μg/ml. The 
precision is exemplified by relative standard deviation of 1.49%. 
Percentage Mean recovery was found to be in the range of 98-102, 
during accuracy studies. The limit of detection (LOD) and limit of 
quantitiation (LOQ) were found to be 5 µg/ml, and 16.27 µg/ml 
respectively. Accordingly it is concluded that the developed UV 
spectrophotometric method is accurate, precise, linear, rugged and 
robust and therefore the method can be used for the routine analysis 
of Indinavir sulphate in tablets in various pharmaceutical industries. 
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